9
The authorization includes the right for the Board to resolve on the repurchase of the company’s own shares through a tender
offer made to all shareholders on equal terms and conditions and at the price determined by the Board, or in public trading
organized by the Nasdaq Helsinki Ltd at the market price valid at any given time, so that the company’s total holding of own
shares does not exceed ten (10) percent of all the shares in the company. The minimum price for the shares to be repurchased
is the lowest market price quoted for the shares in the company in public trading and, correspondingly, the maximum price is
the highest market price quoted for the shares in the company in public trading during the validity of the authorization.
Should the shares in the company be repurchased in public trading, such shares will not be purchased in proportion to the
shareholders’ current holdings. In that case, there must be a weighty financial reason for the company to repurchase its own
shares. The shares may be repurchased in order to be used as consideration in potential acquisitions or in other structural
arrangements. The shares may also be used for carrying out the company’s incentive schemes for its personnel. The repur-
chased shares may be retained by the company, invalidated or transferred further. The repurchase of the company’s own
shares will reduce the non-restricted equity of the company.
The authorization is valid for 18 months from the date of the resolution of the Annual General Meeting starting on April 5,
2023, and ending on October 4, 2024. The authorization replaces the corresponding previous authorization.
The Annual General Meeting held on April 5, 2023, decided to authorize the Board of Directors to resolve on the issuance of a
maximum of 2,500,000 shares through issuance of shares, option rights or other special rights entitling to shares under Chap-
ter 10, Section 1 of the Finnish Companies Act in one or more issues. The authorization includes the right to decide to issue
either new shares or shares held by the company.
The authorization includes the right to deviate from the existing shareholders’ pre-emptive subscription right as set forth in
Chapter 9, Article 3 of the Companies Act. Therefore, the Board of Directors has the right to direct the share issue, or issuance
of the option rights or other special rights conferring entitlement to shares. The authorization also includes the right to decide
on all the terms of share issue, option rights or other special rights conferring entitlement to shares. The authorization there-
fore includes the right to determine share subscription prices, persons entitled to subscribe the shares and other terms and
conditions applicable to the subscription. In order to deviate from the shareholders’ pre-emptive subscription right, the com-
pany must have a weighty financial reason such as financing of a company acquisition, other arrangement in connection with
the development of the company’s business or equity or an incentive scheme to the personnel. In connection with the share
issuance, the Board of Directors is entitled to decide that the shares may be subscribed against contribution in kind or other-
wise under special terms and conditions. The authorization includes the right to determine whether the subscription price will
be entered into the share capital or into the unrestricted equity fund.
The authorization is valid for 18 months from the date of the resolution of the Annual General Meeting starting on April 5,
2023, and ending on October 4, 2024.
SHARES
Etteplan’s shares are listed in Nasdaq Helsinki Ltd’s Mid Cap market capitalization group in the Industrials sector under the
ETTE ticker. The company has one series of shares. All shares confer an equal right to a dividend and the company’s funds.
The company’s share capital on December 31, 2023, was EUR 5,000,000.00 and the total number of shares was 25,200,793.
TRADING IN SHARES
The number of Etteplan Oyj shares traded in January-December was 383,929 (1-12/2022: 517,686), for a total value of EUR
6.08 (8.0) million. The share price low was EUR 12.40, the high EUR 18.65, the average EUR 15.84 and the closing price EUR
13.80. Market capitalization on December 31, 2023, was EUR 346.38 (365.61) million. On December 31, 2023, Etteplan had
3,584 (3,696) shareholders.
OWN SHARES
On May 11, 2023, Etteplan Oyj’s Board of Directors decided to initiate a share repurchase program of own shares in accord-
ance with the authorization given to it by the Annual General Meeting on April 5, 2023, according to which the number of re-
purchased shares will not exceed 30,000 shares and the corresponding number of voting rights.
On December 20, 2023, Etteplan Oyj announced it had completed the repurchase program of its own shares. The repurchases
of shares began on June 2, 2023, and ended on December 19, 2023. During that period, the company acquired a total of
30,000 shares and number of voting rights at an average price of EUR 16.2075 in public trading on Nasdaq Helsinki Ltd for the